Combination Hormone Replacement Therapy

Combination HRT uses both estrogen and a progestogen (progesterone or a synthetic form) to relieve the symptoms that arise as hormones decline during perimenopause and menopause. The estrogen addresses symptoms such as hot flashes, while the progestogen is added to protect the uterine lining. Revibe’s providers tailor the specific hormones and program to your needs.

In a woman with a uterus, taking estrogen alone can cause the uterine lining (endometrium) to overgrow, which raises the risk of endometrial hyperplasia and cancer. Adding a progestogen protects the lining and offsets that risk, which is why combination therapy is standard for women who have not had a hysterectomy.

Combination therapy is generally for women who still have a uterus and are seeking relief from menopausal symptoms. Women without a uterus typically use estrogen alone. Your provider confirms which regimen is appropriate based on your history and symptoms.

Systemic hormone therapy is the most effective treatment for hot flashes and night sweats, and it can also help with sleep disruption, vaginal dryness, mood changes, and bone-loss prevention. Benefits vary by person, and your provider sets expectations based on your situation.

Estrogen and progestogen can be delivered in several forms including pills, patches, gels, and others and can be dosed continuously or cyclically. Your Revibe Health provider chooses the combination and route that best fit your symptoms, preferences, and risk factors.

There is no single fixed duration; the right length of treatment depends on your symptoms, goals, and ongoing benefit-risk assessment, which your provider revisits over time. Many women use it for the years when symptoms are most disruptive.

For many healthy women with bothersome symptoms, the benefits of hormone therapy outweigh the risks, particularly when started before age 60 or within about 10 years of menopause often called the “timing” principle. Risks depend on your age, health history, type of hormones, and route, so care is individualized. Your Revibe provider reviews your personal benefit-risk profile.

Depending on the regimen, hormone therapy can be associated with risks such as blood clots, stroke, and—with certain combination therapies used over time a small increase in breast cancer risk. Common short-term side effects include breast tenderness, bloating, and irregular bleeding. Your Revibe provider weighs these against your symptoms and monitors you.

Hormone therapy is generally avoided in women with a history of certain conditions such as breast cancer, estrogen-sensitive cancers, unexplained vaginal bleeding, active liver disease, or a history of blood clots or stroke. Your Revibe Health provider reviews your full history to determine whether it’s safe for you.